Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):95-7

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

EDITORIAL  BONE METASTASES IN THE ERA OF TARGETED TREATMENTS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):95-7

DOI: 10.23736/S1824-4785.19.03207-2

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Radionuclide imaging and therapy of bone metastases in the era of targeted therapy

Tim Van den WYNGAERT 1, 2 ✉, Frédéric PAYCHA 3, 4

1 Department of Nuclear Medicine, University Hospital of Antwerp, Edegem, Belgium; 2 Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium; 3 Department of Nuclear Medicine, Lariboisière University Hospital, Public Assistance-Paris Hospital, Paris, France; 4 Paris-Diderot University, Paris, France


HTML PDF


top of page

 

Copyright © 2023 Edizioni Minerva Medica

Corporate information        Privacy policy        Terms and conditions